Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joshua M Berlin, MD
Dermatology Associates, PA, of the Palm Beaches
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Study Protocol, Inc.
Boynton Beach, Florida, United States
- Tennessee Clinical Research Center
Nashville, Tennessee, United States
- Stephens & Associates
Carrollton, Texas, United States
- J&s Studies, Inc.
College Station, Texas, United States
- the Dermatology Clinical Research Center of San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2013
- Primary completion
- 31 Mar 2014
- Completion
- 31 Mar 2014
- Last update posted
- 23 Aug 2022
- Registered enrollment
- 81
- Registry id
- NCT01951417
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.